J Diabetes Res. 2025 Mar 29;2025:4744194. doi: 10.1155/jdr/4744194. eCollection 2025.ABSTRACTAims: A lower limb ulcer is a serious complication of diabetes. The association between glycated hemoglobin (HbA1c) and lower limb ulcers needs further clarification. We aimed to comprehensively evaluate the
J Diabetes Res. 2025 Mar 28;2025:6992121. doi: 10.1155/jdr/6992121. eCollection 2025.ABSTRACTBackground: This study investigates the impact of Type 2 diabetes mellitus (T2DM) and depressive symptoms on the health-related quality of life (HRQoL) among patients at the Agricultural General Hospital in
J Diabetes Res. 2025 Mar 24;2025:2640702. doi: 10.1155/jdr/2640702. eCollection 2025.ABSTRACTBackground: This community-based randomised controlled study was aimed at evaluating a health literacy (HL) and diabetes self-management education (DSME) improvement program (HL-DSME program) among people wi
J Diabetes Res. 2025 Mar 18;2025:9966933. doi: 10.1155/jdr/9966933. eCollection 2025.ABSTRACTIntroduction: Type 2 diabetes mellitus poses global health challenges due to insulin resistance and hyperglycaemia. Understanding demographic characteristics and lipid profiles among diabetic patients is cru
J Diabetes Res. 2025 Mar 18;2025:3248350. doi: 10.1155/jdr/3248350. eCollection 2025.ABSTRACTDiabetes is a systemic metabolic disorder primarily caused by insulin deficiency and insulin resistance, leading to chronic hyperglycemia. Prolonged diabetes can result in metabolic damage to multiple organs
J Diabetes Res. 2025 Mar 12;2025:8830658. doi: 10.1155/jdr/8830658. eCollection 2025.ABSTRACTAims: We developed a prediction model for elevated hemoglobin A1c (HbA1c) among patients presenting to the emergency department (ED) at risk for diabetes to identify important factors that may influence foll
J Diabetes Res. 2025 Feb 19;2025:1162708. doi: 10.1155/jdr/1162708. eCollection 2025.ABSTRACTObjective: FKBP5 is a critical gene involved in regulating the hypothalamic-pituitary-adrenal (HPA) axis and stress response. Aberrant DNA methylation at FKBP5 cytosine-phosphate-guanine (CpG) sites, such as
J Diabetes Res. 2025 Feb 14;2025:4563928. doi: 10.1155/jdr/4563928. eCollection 2025.ABSTRACTObjective: Dysglycemia is associated with poor outcomes; the actual status of dysglycemia of critically ill patients with diabetes should refer to background glycemia. We investigated the effect of differenc
J Diabetes Res. 2025 Feb 12;2025:8063481. doi: 10.1155/jdr/8063481. eCollection 2025.ABSTRACTIt is critical to ensure that lifestyle change programs are tailored to the person with prediabetes needs and wishes. However, programs that are carried out in research settings to delay or prevent Type 2 di
J Diabetes Res. 2025 Feb 10;2025:8182211. doi: 10.1155/jdr/8182211. eCollection 2025.ABSTRACTDiabetic kidney disease (DKD) is one of the most life-threatening complications of diabetes and a leading cause of chronic kidney disease. Glucagon-like peptide 1 receptor agonists (GLP1-RAs) or sodium-gluco
J Diabetes Res. 2024 Dec 10;2024:5112055. doi: 10.1155/2024/5112055. eCollection 2024.ABSTRACTOver the past decades, the global prevalence of Type 2 diabetes mellitus (T2D) and impaired glucose tolerance (IGT) has been increasing at an epidemic rate, yet the exact cause remains unknown. It is widely
J Diabetes Res. 2025 Jan 24;2025:1933825. doi: 10.1155/jdr/1933825. eCollection 2025.ABSTRACTAims: This cross-sectional study is aimed at determining whether systemic inflammation, diabetic autoantibodies, and islet β cell dysfunction play a role in the progression of macrovascular complications in
J Diabetes Res. 2025 Jan 16;2025:1273073. doi: 10.1155/jdr/1273073. eCollection 2025.ABSTRACTBackground: Emerging evidence suggests cell exfoliation could be operating under the control of cell metabolism. It is unclear if there are associations between the concentration of exfoliated kidney proxima
J Diabetes Res. 2025 Jan 11;2025:3307594. doi: 10.1155/jdr/3307594. eCollection 2025.ABSTRACTIntroduction: Diabetic nephropathy (DN) and diabetic retinopathy (DR) are serious complications of type 2 diabetes mellitus (T2DM). The reported estimates of prevalence and progression of DN and DR vary wide
J Diabetes Res. 2025 Jan 8;2025:4275741. doi: 10.1155/jdr/4275741. eCollection 2025.ABSTRACTAim: To describe the demographic and clinical characteristics of patients with Charcot neuro-osteoarthropathy (CNO) and to examine for differences between participants with Type 1 diabetes mellitus (DM) (T1DM
J Diabetes Res. 2025 Jan 6;2025:3823051. doi: 10.1155/jdr/3823051. eCollection 2025.ABSTRACTBackground: Shenlian (SL) decoction, a renowned traditional Chinese formula for diabetes mellitus, has also been employed to treat intestinal disorders. Previous studies have demonstrated the efficacy of SL d
J Diabetes Res. 2025 Jan 2;2025:4144787. doi: 10.1155/jdr/4144787. eCollection 2025.ABSTRACTAims: The study was aimed at assessing the role of the MiniMed780G system of glycemic control before, during, and after Ramadan among people with Type 1 diabetes (PwT1D). Methods: This is a single-center retr
J Diabetes Res. 2024 Dec 24;2024:4843889. doi: 10.1155/jdr/4843889. eCollection 2024.ABSTRACTThis study explores a novel healthcare model employed in the primary care setting integrating a carbohydrate-reduction dietary approach and health coaching for managing prediabetes (PD) and Type 2 diabetes (
J Diabetes Res. 2024 Dec 24;2024:7146054. doi: 10.1155/jdr/7146054. eCollection 2024.ABSTRACTBackground: Diabetic liver injury is a serious complication due to the lack of effective treatments and the unclear pathogenesis. Ferroptosis, a form of cell death involving reactive oxygen species (ROS)-dep
J Diabetes Res. 2024 Dec 20;2024:5151171. doi: 10.1155/jdr/5151171. eCollection 2024.ABSTRACTType 1 diabetes (T1D) is an autoimmune chronic disorder that damages beta cells in the pancreatic islets of Langerhans and results in hyperglycemia due to the loss of insulin. Exogenous insulin therapy can s
J Diabetes Res. 2024 Dec 19;2024:2380337. doi: 10.1155/jdr/2380337. eCollection 2024.ABSTRACTBackground: Limited data are available about the epidemiological characteristics and the risk factors for amputation, particularly in developing countries from Asia, especially in China. Objective: We aim to
J Diabetes Res. 2024 Dec 19;2024:8559677. doi: 10.1155/jdr/8559677. eCollection 2024.ABSTRACTBackground and Aims: Coronary heart disease (CHD), hypertension (HTN), depression (Dep), and Type 2 diabetes mellitus (T2DM) are often comorbid, resulting in an exacerbated patient condition and worsened pro
J Diabetes Res. 2024 Dec 19;2024:9933957. doi: 10.1155/jdr/9933957. eCollection 2024.ABSTRACTBackground: Olfactory dysfunction and cognitive impairment (CI) have been associated with Type 2 diabetes (T2DM), but the mechanisms underlying this association are broadly unknown. This systematic review te
J Diabetes Res. 2024 Dec 17;2024:7557153. doi: 10.1155/jdr/7557153. eCollection 2024.ABSTRACTBackground: Young-onset diabetes (YOD) is characterised by unique diagnostic and management challenges more pronounced in resource-limited settings like Sri Lanka. Aims: We aimed to ascertain the prevalence,
